Diagnostic Significance of hsa-miR-21-5p, hsa-miR-192-5p, hsa-miR-155-5p, hsa-miR-199a-5p Panel and Ratios in Hepatocellular Carcinoma on Top of Liver Cirrhosis in HCV-Infected Patients
暂无分享,去创建一个
S. Zaky | M. Alboraie | C. Lambert | N. Hamdy | Omaima I. Abo-Elkheir | N. Abdelmageed | M. Shaheen | Ahmed Elshafei | Reham Hammad | Asmaa A Elmadbouly | A. Abdelbadea | Mona A Eldosoky | R. Aglan | Areej Rushdi | Asmaa A. Elmadbouly | Sherihan G. Abdel-Hamid | D. Hassan | Reem M. Ahmed | Elham Ali
[1] M. Kanehisa,et al. KEGG for taxonomy-based analysis of pathways and genomes , 2022, Nucleic Acids Res..
[2] N. Hamdy,et al. Cytotoxic T Cell Expression of Leukocyte-Associated Immunoglobulin-Like Receptor-1 (LAIR-1) in Viral Hepatitis C-Mediated Hepatocellular Carcinoma , 2022, International journal of molecular sciences.
[3] M. Klammer,et al. Comprehensive evaluation of microRNA as a biomarker for the diagnosis of hepatocellular carcinoma , 2022, World journal of gastroenterology.
[4] E. Badr,et al. MicroRNA-29a and MicroRNA-124 as novel biomarkers for hepatocellular Carcinoma. , 2022, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[5] C. Zhong,et al. JPHYD Inhibits miR-21-5p/Smad7-Mediated Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma Cells , 2022, Journal of oncology.
[6] Xubin Li,et al. A Predictive Nomogram of Early Recurrence for Patients with AFP-Negative Hepatocellular Carcinoma Underwent Curative Resection , 2022, Diagnostics.
[7] E. Børsheim,et al. Circulating microRNAs Are Associated With Metabolic Markers in Adolescents With Hepatosteatosis , 2022, Frontiers in Endocrinology.
[8] Haiyang Yu,et al. Solamargine induces hepatocellular carcinoma cell apoptosis and autophagy via inhibiting LIF/miR-192-5p/CYR61/Akt signaling pathways and eliciting immunostimulatory tumor microenvironment , 2022, Journal of Hematology & Oncology.
[9] Tong Li,et al. A novel prognostic model for hepatocellular carcinoma based on 5 microRNAs related to vascular invasion , 2022, BMC Medical Genomics.
[10] Shinya Takahashi,et al. Current treatment strategies and future perspectives for gastrointestinal stromal tumors , 2022, World journal of gastrointestinal pathophysiology.
[11] N. Hamdy,et al. Competitive Endogenous Role of the LINC00511/miR-185-3p Axis and miR-301a-3p From Liquid Biopsy as Molecular Markers for Breast Cancer Diagnosis , 2021, Frontiers in Oncology.
[12] Song He,et al. Investigation of Potential Molecular Biomarkers for Diagnosis and Prognosis of AFP-Negative HCC , 2021, International journal of general medicine.
[13] N. Hamdy,et al. MicroRNAs’ role in the environment-related non-communicable diseases and link to multidrug resistance, regulation, or alteration , 2021, Environmental Science and Pollution Research.
[14] A. Lohse,et al. Diagnostic and Prognostic Value of miR-16, miR-146a, miR-192 and miR-221 in Exosomes of Hepatocellular Carcinoma and Liver Cirrhosis Patients , 2021, Cancers.
[15] Dan Guo,et al. In vitro and in vivo anti-metastatic effect of the alkaliod matrine from Sophora flavecens on hepatocellular carcinoma and its mechanisms. , 2021, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[16] Kyoung-Jin Oh,et al. Metabolic Spectrum of Liver Failure in Type 2 Diabetes and Obesity: From NAFLD to NASH to HCC , 2021, International journal of molecular sciences.
[17] Pengcheng Zhou,et al. LncRNA XIST upregulates TRIM25 via negatively regulating miR-192 in hepatitis B virus-related hepatocellular carcinoma , 2021, Molecular medicine.
[18] M. Sobh,et al. Role of exopolysaccharides (EPSs) as anti-Mir-155 in cancer cells , 2021, Heliyon.
[19] D. Lancet,et al. GeneCaRNA: a comprehensive gene-centric database of human non-coding RNAs in the GeneCards Suite. , 2021, Journal of molecular biology.
[20] G. Her,et al. RETRACTED: MicroRNA-21 Plays Multiple Oncometabolic Roles in the Process of NAFLD-Related Hepatocellular Carcinoma via PI3K/AKT, TGF-β, and STAT3 Signaling , 2021, Cancers.
[21] D. Ribatti,et al. microRNAs Biogenesis, Functions and Role in Tumor Angiogenesis , 2020, Frontiers in Oncology.
[22] P. Malfertheiner,et al. Circulating miR-21-5p level has limited prognostic value in patients with hepatocellular carcinoma and is influenced by renal function , 2020, World journal of hepatology.
[23] Jairo Navarro Gonzalez,et al. The UCSC SARS-CoV-2 Genome Browser , 2020, Nature Genetics.
[24] M. Ávila,et al. Epigenetics in hepatocellular carcinoma development and therapy: The tip of the iceberg , 2020, JHEP reports : innovation in hepatology.
[25] Min Lin,et al. Emerging role of FBXO22 in carcinogenesis , 2020, Cell Death Discovery.
[26] S. Dima,et al. Plasma Small Extracellular Vesicles Derived miR-21-5p and miR-92a-3p as Potential Biomarkers for Hepatocellular Carcinoma Screening , 2020, Frontiers in Genetics.
[27] A. Romano,et al. Lipid Metabolism in Development and Progression of Hepatocellular Carcinoma , 2020, Cancers.
[28] N. Kawada,et al. The Role of Insulin Resistance and Diabetes in Nonalcoholic Fatty Liver Disease , 2020, International journal of molecular sciences.
[29] David Haussler,et al. The UCSC SARS-CoV-2 Genome Browser , 2020, Nature Genetics.
[30] R. Ahmed,et al. MiR-155 and MiR-665 Role as Potential Non-invasive Biomarkers for Hepatocellular Carcinoma in Egyptian Patients with Chronic Hepatitis C Virus Infection , 2020, Journal of translational internal medicine.
[31] Xiaowei Wang,et al. miRDB: an online database for prediction of functional microRNA targets , 2019, Nucleic Acids Res..
[32] P. Xue,et al. Exosomal miR-21 regulates the TETs/PTENp1/PTEN pathway to promote hepatocellular carcinoma growth , 2019, Molecular Cancer.
[33] Andrea Tsoris,et al. Use Of The Child Pugh Score In Liver Disease , 2019 .
[34] J. Yun,et al. Acidic Microenvironment Up-Regulates Exosomal miR-21 and miR-10b in Early-Stage Hepatocellular Carcinoma to Promote Cancer Cell Proliferation and Metastasis , 2019, Theranostics.
[35] Xiaowei Wang,et al. Prediction of functional microRNA targets by integrative modeling of microRNA binding and target expression data , 2019, Genome Biology.
[36] J. Tu,et al. Current Status and Perspective Biomarkers in AFP Negative HCC: Towards Screening for and Diagnosing Hepatocellular Carcinoma at an Earlier Stage , 2019, Pathology & Oncology Research.
[37] Q. Zhan,et al. miR-192-5p Silencing by Genetic Aberrations Is a Key Event in Hepatocellular Carcinomas with Cancer Stem Cell Features. , 2018, Cancer research.
[38] Y. Takeda,et al. Exosomal miR-155 Derived from Hepatocellular Carcinoma Cells Under Hypoxia Promotes Angiogenesis in Endothelial Cells , 2018, Digestive Diseases and Sciences.
[39] M. Speicher,et al. Current and future perspectives of liquid biopsies in genomics-driven oncology , 2018, Nature Reviews Genetics.
[40] P. Sutphin,et al. Staging systems of hepatocellular carcinoma: A review , 2018, Indian Journal of Gastroenterology.
[41] Xiaoxia Zhou,et al. Low expression of miR-199 in hepatocellular carcinoma contributes to tumor cell hyper-proliferation by negatively suppressing XBP1 , 2018, Oncology letters.
[42] M. Abecassis,et al. Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases , 2018, Hepatology.
[43] P. Schirmacher,et al. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. , 2018, Journal of hepatology.
[44] H. Cortez‐Pinto,et al. miR-21 ablation and obeticholic acid ameliorate nonalcoholic steatohepatitis in mice , 2017, Cell Death & Disease.
[45] Sang Gyune Kim,et al. Usefulness of AFP, AFP-L3, and PIVKA-II, and their combinations in diagnosing hepatocellular carcinoma , 2017, Medicine.
[46] H. Shan,et al. MiR‐199a‐5p suppresses tumorigenesis by targeting clathrin heavy chain in hepatocellular carcinoma , 2017, Cell biochemistry and function.
[47] K. Yoon,et al. Triglycerides/glucose index is a useful surrogate marker of insulin resistance among adolescents , 2017, International Journal of Obesity.
[48] Lili Liu,et al. MiR-199a-5p and let-7c cooperatively inhibit migration and invasion by targeting MAP4K3 in hepatocellular carcinoma , 2017, Oncotarget.
[49] C. Tsao,et al. Emerging role of microRNA-21 in cancer (Review) , 2016 .
[50] F. He,et al. The platelet-to-lymphocyte ratio, superior to the neutrophil-to-lymphocyte ratio, correlates with hepatitis C virus infection. , 2016, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[51] V. Paradis,et al. Liver microRNA-21 is overexpressed in non-alcoholic steatohepatitis and contributes to the disease in experimental models by inhibiting PPARα expression , 2015, Gut.
[52] Artemis G. Hatzigeorgiou,et al. DIANA-miRPath v3.0: deciphering microRNA function with experimental support , 2015, Nucleic Acids Res..
[53] Sreeparna Banerjee,et al. PPARG (peroxisome proliferator-activated receptor gamma) , 2011 .
[54] Tsviya Olender,et al. GeneDecks: paralog hunting and gene-set distillation with GeneCards annotation. , 2009, Omics : a journal of integrative biology.
[55] R. Turner,et al. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.
[56] 威志 三光寺. 顎関節軟骨線維層におけるEGF(Epidermal Growth Factor)の影響について , 1999 .
[57] J. Flier,et al. Insulin resistance--mechanisms, syndromes, and implications. , 1991, The New England journal of medicine.